Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point
- PMID: 1366259
- DOI: 10.3109/08037059209077502
Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point
Abstract
A novel design for intervention studies is presented, the so called PROBE study (Prospective Randomized Open, Blinded End-point). This design is compared to the classical double-blind design. Among the advantages of the PROBE design are lower cost and greater similarity to standard clinical practice, which should make the results more easily applicable in routine medical care. Since end-points are evaluated by a blinded end-point committee it is obvious that there should be no difference between the two types of trials in this regard.
Similar articles
-
Cardiovascular clinical trials in Japan and controversies regarding prospective randomized open-label blinded end-point design.Hypertens Res. 2009 Feb;32(2):109-14. doi: 10.1038/hr.2008.26. Epub 2009 Jan 16. Hypertens Res. 2009. PMID: 19262468 Review.
-
Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project.Diabetes Care. 2001 Dec;24(12):2091-6. doi: 10.2337/diacare.24.12.2091. Diabetes Care. 2001. PMID: 11723089 Clinical Trial.
-
The Captopril Prevention Project (CAPPP): description and status.Am J Hypertens. 1994 Sep;7(9 Pt 2):82S-83S. Am J Hypertens. 1994. PMID: 7818840 Clinical Trial.
-
Prospective, randomized, open-label, blinded-endpoint (PROBE) designed trials yield the same results as double-blind, placebo-controlled trials with respect to ABPM measurements.J Hypertens. 2003 Jul;21(7):1291-8. doi: 10.1097/00004872-200307000-00016. J Hypertens. 2003. PMID: 12817175
-
The combination therapy of hypertension to prevent cardiovascular events (COPE) trial: rationale and design.Hypertens Res. 2005 Apr;28(4):331-8. doi: 10.1291/hypres.28.331. Hypertens Res. 2005. PMID: 16138563 Review.
Cited by
-
Effects of doxazosin and amlodipine on mean platelet volume and serum serotonin level in patients with metabolic syndrome: a randomised, controlled study.Clin Drug Investig. 2007;27(6):435-41. doi: 10.2165/00044011-200727060-00006. Clin Drug Investig. 2007. PMID: 17506593 Clinical Trial.
-
[Effect of Digital Health Interventions on Psychotic Symptoms among Persons with Severe Mental Illness in Community: A Systematic Review and Meta-Analysis].J Korean Acad Nurs. 2023 Feb;53(1):69-86. doi: 10.4040/jkan.22121. J Korean Acad Nurs. 2023. PMID: 36898686 Korean.
-
Effects of levosimendan versus dobutamine on left atrial function in decompensated heart failure.Can J Cardiol. 2009 Oct;25(10):e353-6. doi: 10.1016/s0828-282x(09)70721-4. Can J Cardiol. 2009. PMID: 19812809 Free PMC article. Clinical Trial.
-
FCET2EC (From controlled experimental trial to = 2 everyday communication): How effective is intensive integrative therapy for stroke-induced chronic aphasia under routine clinical conditions? A study protocol for a randomized controlled trial.Trials. 2013 Sep 23;14:308. doi: 10.1186/1745-6215-14-308. Trials. 2013. PMID: 24059983 Free PMC article. Clinical Trial.
-
The Effect of Warfarin Administration Time on Anticoagulation Stability (INRange): A Pragmatic Randomized Controlled Trial.Ann Fam Med. 2020 Jan;18(1):42-49. doi: 10.1370/afm.2488. Ann Fam Med. 2020. PMID: 31937532 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical